
Senior Director, Medical Director – Lung Cancer and Early Pipeline
Posted 2 days ago

Posted 2 days ago
This is a fully remote position, open to applicants in United States, +2 more locations.
• Act as the Medical Affairs lead for the lung cancer therapeutic area and oversee global post-proof of concept pipeline products.
• Direct the Medical FMT for the Solid Tumor Oncology product line.
• Spearhead the development of the annual and long-term US Medical Plan.
• Oversee the creation, upkeep, and implementation of the Integrated Evidence Generation Plan, which includes investigator-sponsored studies, real-world evidence initiatives, health outcomes research, and appropriate Phase IV interventional studies.
• Guide the formulation of the scientific narrative by pinpointing and advancing critical analytic needs and facilitating the interpretation of pivotal trial data.
• Represent and champion medical viewpoints within global cross-functional teams and governance forums, such as GPT, CDT, PGC, and DPRC.
• Provide Medical Affairs expertise to early development initiatives, including the development of Target Product Profiles, clinical trial designs, and lifecycle strategies.
• Ensure that regional needs and insights are integrated into early and clinical development discussions, evidence generation efforts, and lifecycle strategies.
• Maintain alignment within Medical Affairs for early and clinical development programs.
• Utilize insights into the competitive landscape to shape evidence generation strategies and internal development decisions.
• Collaborate with Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, RWE, Commercial, and other cross-functional teams.
• Lead the formulation and execution of publication strategies and plans.
• Assist with scientific communications, congress planning, advisory boards, and activities for external engagement.
• A minimum of 10 years of experience in Medical Affairs, Clinical Development, or related fields within the pharmaceutical or biotechnology industry is essential, with a preference for oncology experience.
• Strong preference for experience in lung cancer therapies.
• Proven track record in developing and implementing evidence-generation strategies, publication plans, and engaging with external scientific stakeholders.
• Comprehensive understanding of clinical research, evidence generation, and drug development processes.
• Demonstrated capacity to influence stakeholders without direct authority and function effectively in complex matrix organizations.
• Strong strategic mindset combined with exceptional operational execution abilities.
• Excellent written, verbal, presentation, and stakeholder management skills.
• Ability to cultivate productive partnerships across various regions and functions while effectively representing diverse stakeholder perspectives.
• Proven ability to manage multiple priorities and achieve high-quality results in a fast-paced environment.
• Experience in the lifecycle management of lung cancer indications is highly desired.
• Evidence of success in matrix organizations, showcasing high-performing behaviors, including independent critical thinking, initiative, and effective execution under time constraints with competing priorities.
• Self-awareness and emotional intelligence demonstrated through prior experience in successfully navigating complex matrix environments.
• An advanced scientific or healthcare degree is required (PharmD, PhD, MD, MBBS, Nurse Practitioner, PA, or equivalent).
• Experience in the provision of oncology care is preferred.
• Discretionary annual cash bonus or incentive compensation.
• Discretionary equity grants.
• Medical insurance.
• Dental insurance.
• Vision insurance.
• 401k retirement savings plan.
• Flexible paid vacation.
Precision Medicine Group
DocGo
PRECISIONvalue
Council Capital
Get handpicked remote jobs straight to your inbox weekly.